Recent Finacing
Recent Raise
Parabilis Medicines is a clinical-stage biopharmaceutical company using its Helicon™ peptide platform to develop first-in-class cancer therapies that target proteins long considered undruggable.
Focus Areas
Recent Investors
Total Raised
Funding round
See the team members at Parabilis Medicines.
